Dr. Chloe Thio is a professor of medicine and an associate professor of molecular microbiology and immunology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include hepatitis, HIV/AIDS and infectious disease. Dr. Thio received her B.A. from the University of Pennsylvania. She earned her M.D. from the Yale University School of Medicine. She completed her residency at Hospital of the University of Pennsylvania and her fellowship in infectious diseases at Johns Hopkins. Her research interests include chronic hepatitis B and C and coinfection of viral hepatitis with HIV/AIDS. She has developed a program centered around virology and immunology translational work towards an HBV cure. Dr. Thio is a member of the American College of Physicians, the American Association for the Study of Liver Disease, the American Society of Clinical Investigation, HIVMA and the Infectious Diseases Society of America. Dr. Thio is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, and HIV/AIDS.

Dr. Ashwin Balagopal is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is infectious diseases. After receiving his medical degree from Mount Sinai School of Medicine, Dr. Balagopal completed his residency in internal medicine at Yale-New Haven Hospital. He performed his fellowship in infectious diseases at the Johns Hopkins University School of Medicine. Dr. Balagopal's research interests include microbial translocation and Kupffer cells in HIV-HCV coinfection and in situ liver studies of HIV-HCV pathogenesis. Dr. Balagopal is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis, Hepatitis C, HIV/AIDS, and Hepatitis B.

Dr. Gurakar joined Johns Hopkins from the Nazih Zuhdi Transplantation Institute at the Integris Baptist Medical Center in Oklahoma City, where he was the chief of Hepatology Research and the program director of the Liver Transplantation Medicine/ Hepatology Fellowship. He served at various capacities in the Liver Medicine Section, since its first establishment in 1993. Dr. Gurakar's clinical interests include pre and post-transplant, clinical and endoscopic management of liver diseases and viral hepatitis. His research interests include bioartificial liver dialysis systems and application of total plasma exchange in the treatment of liver disorders. Dr. Gurakar is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis, Liver Failure, Alcoholic Cirrhosis, Liver Transplant, and Kidney Transplant.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.

Dr. Moon’s area of clinical expertise is infectious diseases. She earned her M.D. at the Ross University School of Medicine. Dr. Moon completed her residency at Allegheny General Hospital and performed a fellowship in infectious diseases at Penn State Milton S. Hershey Medical Center. Dr. Moon is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Hepatitis C, Hepatitis, Osteomyelitis, and HIV/AIDS.

Jeremy Sugarman, MD, MPH, MA is the Harvey M. Meyerhoff Professor of Bioethics and Medicine, professor of medicine, professor of Health Policy and Management, and deputy director for medicine of the Berman Institute of Bioethics at the Johns Hopkins University. He is an internationally recognized leader in bioethics with particular expertise in applying empirical methods and evidence-based standards for evaluating and analyzing bioethical issues. His contributions to bioethics and policy include his work on the ethics of informed consent, umbilical cord blood banking, stem cell research, international HIV prevention research, global health and research oversight. Dr. Sugarman is the author of over 400 articles, reviews and book chapters. He has also edited or co-edited four books (Beyond Consent: Seeking Justice in Research; Ethics of Research with Human Subjects: Selected Policies and Resources; Ethics in Primary Care; and Methods in Medical Ethics). Dr. Sugarman is on the editorial boards of several academic journals. Dr. Sugarman consults and speaks internationally on a range of issues related to bioethics. He was senior policy and research analyst for the White House Advisory Committee on Human Radiation Experiments, consultant to the National Bioethics Advisory Commission, and Senior Advisor to the Presidential Commission for the Study of Bioethical Issues. He also served on the Maryland Stem Cell Research Commission. He was the founding director of the Trent Center for Bioethics, Humanities and History of Medicine at Duke University where he was also a professor of medicine and philosophy. He was appointed as an Academic Icon at the University of Malaya and is a faculty affiliate of the Kennedy Institute of Ethics at Georgetown University. Dr. Sugarman was the longstanding chair of the Ethics Working Group of the HIV Prevention Trials Network. He is currently a member of the Scientific and Research Advisory Board for the Canadian Blood Service and the Ethics and Public Policy Committees of the International Society for Stem Cell Research. He co-leads the Ethics and Regulatory Core of the NIH Pragmatic Trials Collaboratory and is co-chair of the Johns Hopkins’ Institutional Stem Cell Research Oversight Committee. Dr. Sugarman has been elected as a member of the American Society of Clinical Investigation, Association of American Physicians, and the National Academy of Medicine (formerly the Institute of Medicine). He is a fellow of the American Association for the Advancement of Science, the American College of Physicians and the Hastings Center. He also received a Doctor of Science, honoris causa, from New York Medical College. Dr. Sugarman is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Ventricular Fibrillation, Hepatitis, Hepatitis B, and Kidney Transplant.

Dr. David Lee Thomas is the Stanhope Bayne-Jones professor of medicine at the Johns Hopkins University School of Medicine and of epidemiology at the Bloomberg School of Public Health. He is trained in internal medicine and infectious diseases and cares for patients with chronic viral hepatitis and HIV. From 2006-2022, Dr. Thomas served as the director of the Division of Infectious Diseases. He established, led, and continues to contribute to the Viral Hepatitis Center at Johns Hopkins. He came to Johns Hopkins in 1990 to obtain training in infectious diseases and global health and joined the faculty at the School of Medicine in October 1993. For his commitment to translating medical research into advances in the care of people living with both hepatitis C and HIV, Thomas has received numerous awards. In 2001, he was elected to the American Society of Clinical Investigation and then elected into the American Association of Physicians for which he served on Council. He received a MERIT award from the National Institutes of Health. From the Infectious Diseases Society of America, he has received the Citation award as well as the Walter Stamm award for mentoring. He was also recognized by the Johns Hopkins University with its highest award (the Provost's award) for outstanding mentoring. Dr. Thomas is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis C, Hepatitis, and Hepatitis B.

Kathleen Schwarz is a Hepatologist in Baltimore, Maryland. Dr. Schwarz is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, Sclerosing Cholangitis, and Liver Transplant.

Dr. Wikrom Karnsakul is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. His clinical interests are in the care of pediatric liver diseases, and general gastrointestinal diseases. Dr. Karnsakul received his medical degree in 1992 from Faculty of Medicine, Siriraj Medical Center, Mahidol University School of Medicine in Bangkok, Thailand. He completed his residency in pediatrics at Advocate Hope Children's Hospital in 1998 and did a fellowship in pediatric gastroenterology, hepatology and nutrition at Texas Children's Hospital, Baylor College of Medicine in Houston, Texas. He completed his postdoctoral research training at USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine. He joined the faculty at Johns Hopkins in 2008. His research interests center on the understanding and treatment of chronic liver disease, ascites, cholestasis, viral hepatitis especially hepatitis C and hepatitis E, and Cystic Fibrosis Related Liver Disease. Dr. Karnsakul is also involved in NIH-funded multicenter research studies including the Cholestatic Liver Disease Consortium and Cystic Fibrosis Related Liver Disease Project. Dr. Karnsakul is currently a Fellow of the American Association for the Study of Liver Diseases (FAASLD). Dr. Karnsakul is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Alagille Syndrome, Cholestasis, Hepatitis E, Liver Transplant, and Endoscopy.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Petros Karakousis is a Professor of Medicine at the Johns Hopkins University School of Medicine. He has joint appointments in Molecular Microbiology & Immunology and International Health at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include infectious diseases and tuberculosis. Dr. Karakousis received his undergraduate degree in 1994 from the Johns Hopkins University and his medical degree in 1998 from Washington University School of Medicine in St. Louis. He completed residency training in internal medicine in 2001 at the Hospital of the University of Pennsylvania. After completing fellowship training in infectious diseases at Johns Hopkins, he joined the Department of Medicine faculty in 2005. His research interests include tuberculosis pathogenesis, Mycobacterium tuberculosis persistence and antibiotic tolerance, host-pathogen interactions and host-directed therapies. Dr. Karakousis was named a Fellow of the Infectious Diseases Society of America in 2010, and was elected to the American Society for Clinical Investigation in 2021. He has held numerous leadership positions, including in the Working Group on New TB Drugs of the Stop TB Partnership. He has served on the editorial board of various scientific journals and on numerous NIH study sections, and as a peer reviewer for many international government and private funding agencies. Dr. Karakousis is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection.

Dr. Susan Tuddenham is an associate professor of medicine at the Johns Hopkins University School of Medicine. She received her M.P.H. from the Johns Hopkins Bloomberg School of Public Health and her M.D. from the David Geffen School of Medicine at UCLA. She completed her residency in internal medicine and her fellowship in infectious diseases at the Johns Hopkins Hospital. Her research interests are in sexually transmitted infections, HIV, and the human microbiome in the context of infectious diseases. Her outpatient clinical practice focuses on recurrent vaginitis (including Bacterial Vaginosis and Vulvovaginal Candidiasis), Sexually Transmitted Infections, and recurrent Urinary Tract Infections in women. Dr. Tuddenham is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Neurosyphilis, Syphilis, Gonorrhea, and Vaginal Yeast Infection.

Dr. Trevor Crowell is an adjunct assistant professor at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS, sexually transmitted infections, and other infectious diseases. Dr. Crowell earned his M.D. from the University of Southern California Keck School of Medicine and his Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He completed his residency at Case Western Reserve University/University Hospitals Case Medical Center and completed a fellowship in infectious diseases at Johns Hopkins. In addition to serving as a staff physician at Bayview Medical Center, Dr. Crowell is an Associate Director at the U.S. Military HIV Research Program, Walter Reed Army Institute of Research. He is also an assistant professor of medicine at the Uniformed Services University of the Health Sciences. Dr. Crowell is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Gonorrhea, Sepsis, and Chlamydia.

Dr. Oluwaseun O. Falade-Nwulia is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include infectious disease. Dr. Falade-Nwulia earned her M.B.B.S. from the University of Ibadan Medical School College of Medicine. She completed her residency at Johns Hopkins Bayview Medical Center. She performed fellowships in infectious diseases at Johns Hopkins and a fellowship in critical care medicine at the National Institutes of Health. Dr. Falade is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Sepsis.

Hepatologist Merve Gurakar specializes in liver disease, and treats patients who have portal hypertension. Dr. Gurakar earned her medical degree from Virginia Commonwealth University School of Medicine and completed internal medicine residency training at the Johns Hopkins University School of Medicine. She remained at Johns Hopkins for fellowship training in gastroenterology and transplant hepatology. Her research interests include portal hypertension, endo-hepatology and global health. Dr. Gurakar is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Acute Pancreatitis, Hereditary Pancreatitis, Pancreas Divisum, Liver Transplant, and Aneurysm Repair.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Natarajan Ravendhran is a hepatologist specializing in the diagnosis, treatment and management of liver diseases. He received his medical degree from Stanley Medical College, University of Madras in India, completed his residency in internal medicine at what is now Ascension Saint Agnes Hospital in Maryland and a residency in surgery at Railway Hospital in Madras, India. Dr. Ravendhran performed fellowship training in hepatology under the mentorship of Eugene and Leon Schiff at the University of Miami. Additionally, he received fellowship training in gastroenterology and liver disease at the University of Missouri. Dr. Ravendhran received a master’s degree in business administration in medical services management from The Johns Hopkins University. He is a fellow of the American Association for the Study of Liver Diseases and the American Gastroenterological Association, and is a member of the European Association for the Study of the Liver. Dr. Ravendhran is interested in exploring cholestatic disorders. He has participated in many clinical trials that focus on hepatitis B and C, in addition to metabolic dysfunction-associated steatotic liver disease trials. He enjoys teaching, rounding with fellows and seeing patients, and his motto is “Patients come first!”. Dr. Ravendhran is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Hepatitis, Visceromegaly, Enlarged Liver, and Endoscopy.

Lydia Tang is an Infectious Disease provider in Baltimore, Maryland. Dr. Tang is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, and Liver Failure. Dr. Tang is currently accepting new patients.

Joel Chua is an Infectious Disease provider in Baltimore, Maryland. Dr. Chua is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Hepatitis, and Osteomyelitis.